Massie Technology Group, Inc.

Ophthalmic AI Driven Retinal Scanning Technology - Patent Pending - Ready for Market

Massie Technology Group, Inc, “MTG”

San Ramon, CA

Introducing APEX — A Breakthrough AI + Advanced Optics Retinal Imaging Platform for Pediatric and Adult Diagnostics

Massie Technology Group, Inc. (MTG) is introducing the APEX, a patent‑pending retinal imaging platform that combines advanced precision optics with AI‑driven diagnostic capabilities. APEX is designed for Early detection of ophthalmic, neurologic, metabolic, and oncologic disease through oculomics

The Medical Diagnostic Gap

• Current retinal imaging often fails in patients with dark skin pigmentation and in remote or resource‑limited settings

• Missed or delayed diagnoses lead to preventable vision loss and late detection of systemic disease

• No existing platform combines precision optics + AI to close this gap at scale

Our Solution - APEX

• AI‑enhanced retinal scanning platform delivering breakthrough optics + AI enabling high precision retinal imaging across all skin tones and clinical environments

• Detects early signals of ophthalmic, neurologic, metabolic, and oncologic disease

• Represents a major advancement in predictive health through Oculomics

• Patent pending; engineered for clinical reliability and global deployment

Business/Market Fundamentals

• $2B TAM across neonatal/pediatric and adult markets

• Patent pending technology with strong defensibility

• Experienced management team – extensive technology, medical, manufacturing and sales presence in Retinal Imaging markets

• Numerous Key Decision Maker ophthalmologists (KOLs) supportive of APEX technology - eager for continued applications development,
publications, and early purchase of APEX

For additional information about MTG – Apex Technology and investment details

please contact Nathan Messinger, Chief Operating Officer

912.656.2696 or [email protected]

Nathan Messinger

Chief Operating Officer
Lead Investor Contact

Massie Technology Group, Inc.

N.A. (Bert) Massie, PhD

Founder, Chairman & CEO

Paul Rychwalski, MD – Chief Medical Officer – MTG, Inc.

Chief & Professor of Ophthalmology/Pediatrics

Univ. Nebraska, Omaha, NE

Fundraise Details

This section is only visible to registered investors. Log in or register as an accredited investor to view.

Ready to Ask For Funding for your company?

Post a Funding Request

Massie Technology Group, Inc.

Fundraise Details

Key Facts